Validation and clinical application of a method to quantify nevirapine in dried blood spots and dried breast-milk spots

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 10, 2015, Pages 2816-2822

  Olagunju, Adeniyi ^a,b   Amara, Alieu ^a   Waitt, Catriona ^a   Else, Laura ^a   Penchala, Sujan D ^a   Bolaji, Oluseye ^b   Soyinka, Julius ^b   Siccardi, Marco ^a   Back, David ^a   Owen, Andrew ^a   Khoo, Saye ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

NEVIRAPINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACCURACY; ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD CHEMISTRY; BREAST MILK; DRIED BLOOD SPOT TESTING; DRIED BREAST MILK SPOT; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LIQUID CHROMATOGRAPHY; MATERNAL PLASMA; MAXIMUM PLASMA CONCENTRATION; PLASMA CLEARANCE; POST EXPOSURE PROPHYLAXIS; QUANTITATIVE ANALYSIS; ROOM TEMPERATURE; TANDEM MASS SPECTROMETRY; VALIDATION STUDY; CHEMISTRY; DRUG MONITORING; DRUG STABILITY; PLASMA; PROCEDURES; REPRODUCIBILITY; STANDARDS;

ADULT; ANTI-HIV AGENTS; CHROMATOGRAPHY, LIQUID; DRUG MONITORING; DRUG STABILITY; FEMALE; HUMANS; MILK, HUMAN; NEVIRAPINE; PLASMA; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY;

EID: 84943804434     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkv174     Document Type: Article

References (34)

1. WHO. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection. http://www.who.int/iris/bitstream/10665/85321/1/9789241505727_eng.pdf.
2. von Hentig N, Carlebach A, Gute P et al. A comparison of the steadystate pharmacokinetics of nevirapine in men, nonpregnant women and women in late pregnancy. Br J Clin Pharmacol 2006; 62: 552-9.
3. Mirkuzie AH, Hinderaker SG, Sisay MM et al. Current status of medication adherence and infant follow up in the prevention of mother to child HIV transmission programme in Addis Ababa: a cohort study. J Int AIDS Soc 2011; 14: 50.
4. Lamorde M, Byakika-Kibwika P, Okaba-Kayom V et al. Suboptimal nevirapine steady-state pharmacokinetics during intrapartum compared with postpartum in HIV-1-seropositive Ugandan women. J Acquir Immune Defic Syndr 2010; 55: 345-50.
5. Fillekes Q, Mulenga V, Kabamba D et al. Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tablets. AIDS 2012; 26: 1795-800.
6. Foissac F, Bouazza N, Frange P et al. Evaluation of nevirapine dosing recommendations in HIV-infected children. Br J Clin Pharmacol 2013; 76: 137-44.
7. Olagunju A, Bolaji OO, Amara A et al. Development, validation and clinical application of a novel method for the quantification of efavirenz in dried breast milk spots using LC-MS/MS. J Antimicrob Chemother 2015; 70: 555-61.
8. EMA. Guideline on Validation of Bioanalytical Methods. London: Committee for Medicinal Products for Human Use. http://www.ema. europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf.
9. FDA. Guidance for Industry: Bioanalytical Method Validation. Silver Spring, MD: FDA, US Department of Health and Human Services. http://www.fda. gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidan ces/ucm070107.pdf.
10. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem 2003; 75: 3019-30.
11. KromdijkW, Mulder JW, Rosing H et al. Use of dried blood spots for the determination of plasma concentrations of nevirapine and efavirenz. J Antimicrob Chemother 2012; 67: 1211-6.
12. Koal T, Burhenne H, Romling R et al. Quantification of antiretroviral drugs in dried blood spot samples by means of liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 2005; 19: 2995-3001.
13. D'Avolio A, Simiele M, Siccardi M et al. HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions. J Pharm Biomed Anal 2010; 52: 774-80.
14. Calcagno A, D'Avolio A, Simiele M et al. Influence of CYP2B6 and ABCB1 SNPs on nevirapine plasma concentrations in Burundese HIV-positive patients using dried sample spot devices. Br J Clin Pharmacol 2012; 74: 134-40.
15. Amara AB, Else LJ, Tjia J et al. A validated method for quantification of efavirenz in dried blood spots using high-performance liquid chromatography-mass spectrometry. Ther Drug Monit 2015; 37: 220-8.
16. Olagunju A, Bolaji O, Amara A et al. Pharmacogenetics of pregnancyinduced changes in efavirenz pharmacokinetics. Clin Pharmacol Ther 2015; 97: 298-306.
17. DenniffP, Spooner N. The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs. Bioanalysis 2010; 2: 1385-95.
18. Li W, Tse FL. Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules. Biomed Chromatogr 2010; 24: 49-65.
19. ter Heine R, Rosing H, van Gorp EC et al. Quantification of protease inhibitors and non-nucleoside reverse transcriptase inhibitors in dried blood spots by liquid chromatography-triple quadrupole mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2008; 867: 205-12.
20. Rezk NL, Abdel-Megeed MF, Kashuba AD. Development of a highly efficient extraction technique and specific multiplex assay for measuring antiretroviral drug concentrations in breast milk. Ther Drug Monit 2007; 29: 429-36.
21. Rezk NL, White N, Bridges AS et al. Studies on antiretroviral drug concentrations in breast milk: validation of a liquid chromatographytandem mass spectrometric method for the determination of 7 antihuman immunodeficiency virus medications. Ther Drug Monit 2008; 30: 611-9.
22. Shapiro RL, Holland DT, Capparelli E et al. Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment. J Infect Dis 2005; 192: 720-7.
23. Mirochnick M, Thomas T, Capparelli E et al. Antiretroviral concentrations in breast-feeding infants of mothers receiving highly active antiretroviral therapy. Antimicrob Agents Chemother 2009; 53: 1170-6.
24. Wilson JT, Brown RD, Cherek DR et al. Drug excretion in human breast milk: principles, pharmacokinetics and projected consequences. Clin Pharmacokinet 1980; 5: 1-66.
25. Ito S. Drug therapy for breast-feeding women. N Engl J Med 2000; 343: 118-26.
26. Shiau S, Kuhn L. Antiretroviral treatment in HIV-infected infants and young children: novel issues raised by the Mississippi baby. Expert Rev Anti Infect Ther 2014; 12: 307-18.
27. Joint United Nations Programme on HIV/AIDS. Global Report: UNAIDS Report on the Global AIDS Epidemic 2013. Geneva: UNAIDS, 2013. http://www.unaids.org/sites/default/files/media_asset/UNAIDS_Global_ Report_2013_en_1.pdf.
28. Palumbo P, Lindsey JC, Hughes MD et al. Antiretroviral treatment for children with peripartum nevirapine exposure. NEngl JMed2010; 363: 1510-20.
29. Violari A, Lindsey JC, Hughes MD et al. Nevirapine versus ritonavirboosted lopinavir for HIV-infected children. N Engl J Med 2012; 366: 2380-9.
30. Alvarez-Uria G, Pakam R, Naik PK et al. Induction with lopinavir-based treatment followed by switch to nevirapine-based regimen versus nonnucleoside reverse transcriptase inhibitors-based treatment for first line antiretroviral therapy in HIV infected children three years and older. PLoS One 2014; 9: e108063.
31. Wang J, Kou H, Fu Q et al. Nevirapine plasma concentrations are associated with virologic response and hepatotoxicity in Chinese patients with HIV infection. PLoS One 2011; 6: e26739.
32. Duong M, Buisson M, Peytavin G et al. Low trough plasma concentrations of nevirapine associated with virologic rebounds in HIV-infected patients who switched from protease inhibitors. Ann Pharmacother 2005; 39: 603-9.
33. Gunda DW, Kasang C, Kidenya BR et al. Plasma concentrations of efavirenz and nevirapine among HIV-infected patients with immunological failure attending a tertiary hospital in North-Western Tanzania. PLoS One 2013; 8.
34. Veldkamp AI, Weverling GJ, Lange JMA et al. High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals. AIDS 2001; 15: 1089-95.